Click to search for your profile
Click to search for condition or expert
Click to open main menu
Save Condition
Bookmark
Share
Share
Condition
Late-Onset Retinal Degeneration
Symptoms, Doctors, Treatments, Advances & More
Overview
Find a Doctor
Latest Advances
Clinical Trials
Condition 101
About Late-Onset Retinal Degeneration
What are the alternative names for Late-Onset Retinal Degeneration?
Pigmentary retinopathy
Autosomal dominant late-onset retinal degeneration
Retinal degeneration, late-onset, autosomal dominant
LORD
Top Global Doctors
For Late-Onset Retinal Degeneration
Bookmark
Click to see options
RS
Elite
Rishi P. Singh
Ophthalmology
Cleveland, OH
Bookmark
Click to see options
EC
Elite
Emily Y. Chew
Ophthalmology
Bethesda, MD
Bookmark
Click to see options
JE
Elite
Justis P. Ehlers
Ophthalmology
Cleveland, OH
Bookmark
Click to see options
UE
Elite
Ursula M. Erfurth-Schmidt
Vienna, AT
Bookmark
Click to see options
GJ
Elite
Glenn J. Jaffe
Ophthalmology
Durham, NC
Bookmark
Click to see options
CC
Elite
Christine A. Curcio
Psychiatry
Neurology
Urology
Glen Oaks, NY
Latest Advances
On Late-Onset Retinal Degeneration
Condition:
Chronic Diabetic Macular Edema
Journal:
Scientific reports
Treatment Used:
Fluocinolone Acetonide (FAc) Vitreous Insert
Number of Patients:
0
Published —
February 27, 2021
This review of the literature examined fluocinolone acetonide (FAc) intravitreal implant for patients with chronic diabetic macular edema (DMO).
Condition:
Non-infectious Intraocular Inflammation after Intravitreal Anti-Vascular Endothelial Growth Factor Injection
Journal:
Turkish journal of ophthalmology
Treatment Used:
Topical Steroid Therapy
Number of Patients:
1966
Published —
February 26, 2021
The study researched the use of non-infectious intraocular inflammation after intravitreal anti-vascular endothelial growth factor injection for the treatment of neovascular age-related macular degeneration (nAMD).
Clinical Trials
For Late-Onset Retinal Degeneration
Clinical Trial
Status:
Not yet recruiting
Intervention Type:
Diagnostic Test
Participants:
50
Start Date:
February 2022
Snapshot 3D Ultra-high-resolution OCT and Hyperspectral AF of In-vivo Retina
Clinical Trial
Status:
Not yet recruiting
Phase:
Phase 2
Intervention Type:
Other, Biological
Participants:
132
Start Date:
July 31, 2021
A Phase 2 Multi-Center Trial Evaluating Intravitreal AAVCAGsCD59 Compared to Sham Injection for the Treatment of Advanced Dry Age-Related Macular Degeneration (AMD) With Geographic Atrophy (GA)
